1ioz
From Proteopedia
|  (New page: 200px<br /> <applet load="1ioz" size="450" color="white" frame="true" align="right" spinBox="true"  caption="1ioz, resolution 2.0Å" /> '''CRYSTAL STRUCTURE OF...) | |||
| Line 1: | Line 1: | ||
| - | [[Image:1ioz.gif|left|200px]]<br /> | + | [[Image:1ioz.gif|left|200px]]<br /><applet load="1ioz" size="350" color="white" frame="true" align="right" spinBox="true"  | 
| - | <applet load="1ioz" size=" | + | |
| caption="1ioz, resolution 2.0Å" /> | caption="1ioz, resolution 2.0Å" /> | ||
| '''CRYSTAL STRUCTURE OF THE C-HA-RAS PROTEIN PREPARED BY THE CELL-FREE SYNTHESIS'''<br /> | '''CRYSTAL STRUCTURE OF THE C-HA-RAS PROTEIN PREPARED BY THE CELL-FREE SYNTHESIS'''<br /> | ||
| ==Overview== | ==Overview== | ||
| - | Multi-wavelength anomalous diffraction phasing is especially useful for | + | Multi-wavelength anomalous diffraction phasing is especially useful for high-throughput structure determinations. Selenomethionine substituted proteins are commonly used for this purpose. However, the cytotoxicity of selenomethionine drastically reduces the efficiency of its incorporation in in vivo expression systems. In the present study, an improved E. coli cell-free protein synthesis system was used to incorporate selenomethionine into a protein, so that highly efficient incorporation could be achieved. A milligram quantity of selenomethionine-containing Ras was obtained using the cell-free system with dialysis. The mass spectrometry analysis showed that more than 95% of the methionine residues were substituted with selenomethionine. The crystal of this protein grew under the same conditions and had the same unit cell constants as those of the native Ras protein. The three-dimensional structure of this protein, determined by multi-wavelength anomalous diffraction phasing, was almost the same as that of the Ras protein prepared by in vivo expression. Therefore, the cell-free synthesis system could become a powerful protein expression method for high-throughput structure determinations by X-ray crystallography. | 
| ==Disease== | ==Disease== | ||
| Line 11: | Line 10: | ||
| ==About this Structure== | ==About this Structure== | ||
| - | 1IOZ is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with GDP as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http:// | + | 1IOZ is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=GDP:'>GDP</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1IOZ OCA].  | 
| ==Reference== | ==Reference== | ||
| Line 20: | Line 19: | ||
| [[Category: Kodama, K.]] | [[Category: Kodama, K.]] | ||
| [[Category: Matsuda, T.]] | [[Category: Matsuda, T.]] | ||
| - | [[Category: RSGI, RIKEN | + | [[Category: RSGI, RIKEN Structural Genomics/Proteomics Initiative.]] | 
| [[Category: Yabuki, T.]] | [[Category: Yabuki, T.]] | ||
| [[Category: Yamaguchi-Nunokawa, E.]] | [[Category: Yamaguchi-Nunokawa, E.]] | ||
| Line 32: | Line 31: | ||
| [[Category: structural genomics]] | [[Category: structural genomics]] | ||
| - | ''Page seeded by [http:// | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 13:14:05 2008'' | 
Revision as of 11:14, 21 February 2008
| 
 | 
CRYSTAL STRUCTURE OF THE C-HA-RAS PROTEIN PREPARED BY THE CELL-FREE SYNTHESIS
| Contents | 
Overview
Multi-wavelength anomalous diffraction phasing is especially useful for high-throughput structure determinations. Selenomethionine substituted proteins are commonly used for this purpose. However, the cytotoxicity of selenomethionine drastically reduces the efficiency of its incorporation in in vivo expression systems. In the present study, an improved E. coli cell-free protein synthesis system was used to incorporate selenomethionine into a protein, so that highly efficient incorporation could be achieved. A milligram quantity of selenomethionine-containing Ras was obtained using the cell-free system with dialysis. The mass spectrometry analysis showed that more than 95% of the methionine residues were substituted with selenomethionine. The crystal of this protein grew under the same conditions and had the same unit cell constants as those of the native Ras protein. The three-dimensional structure of this protein, determined by multi-wavelength anomalous diffraction phasing, was almost the same as that of the Ras protein prepared by in vivo expression. Therefore, the cell-free synthesis system could become a powerful protein expression method for high-throughput structure determinations by X-ray crystallography.
Disease
Known diseases associated with this structure: Bladder cancer, somatic OMIM:[190020], Costello syndrome OMIM:[190020], Thyroid carcinoma, follicular, somatic OMIM:[190020]
About this Structure
1IOZ is a Single protein structure of sequence from Homo sapiens with as ligand. Full crystallographic information is available from OCA.
Reference
Selenomethionine incorporation into a protein by cell-free synthesis., Kigawa T, Yamaguchi-Nunokawa E, Kodama K, Matsuda T, Yabuki T, Matsuda N, Ishitani R, Nureki O, Yokoyama S, J Struct Funct Genomics. 2002;2(1):29-35. PMID:12836672
Page seeded by OCA on Thu Feb 21 13:14:05 2008
Categories: Homo sapiens | Single protein | Kigawa, T. | Kodama, K. | Matsuda, T. | RSGI, RIKEN Structural Genomics/Proteomics Initiative. | Yabuki, T. | Yamaguchi-Nunokawa, E. | GDP | Cell-free protein synthesis | Gtp-binding protein | Oncogene protein | Ras | Riken structural genomics/proteomics initiative | Rsgi | Structural genomics
